Anne Börjesson-Hanson

Publications
Public outreach and news

Articles

Article: NATURE MEDICINE. 2023;29(6):1437-1447
Tau-targeting antisense oligonucleotide MAPT_Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial
Mummery CJ; Borjesson-Hanson A; Blackburn DJ; Vijverberg EGB; De Deyn PP; Ducharme S; Jonsson M; Schneider A; Rinne JO; Ludolph AC; Bodenschatz R; Kordasiewicz H; Swayze EE; Fitzsimmons B; Mignon L; Moore KM; Yun C; Baumann T; Li D; Norris DA; Crean R; Graham DL; Huang E; Ratti E; Bennett CF; Junge C; Lane RM
Article: FRONTIERS IN NEUROLOGY. 2020;11:149
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.
Abdullah L; Crawford F; Tsolaki M; Börjesson-Hanson A; Olde Rikkert M; Pasquier F; Wallin A; Kennelly S; Ait-Ghezala G; Paris D; Hendrix S; Blennow K; Lawlor B; Mullan M
Article: NEUROBIOLOGY OF AGING. 2019;79:131-141
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease
Timmers M; Tesseur I; Bogert J; Zetterberg H; Blennow K; Borjesson-Hanson A; Baquero M; Boada M; Randolph C; Tritsmans L; Van Nueten L; Engelborghs S; Streffer JR
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(10):e011938
Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension.
de Heus RAA; Donders R; Santoso AMM; Olde Rikkert MGM; Lawlor BA; Claassen JAHR; Nilvad Study Group
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2019;47(1-2):114-124
Amyloid β42 and Total Tau Levels in Cerebrospinal Fluid Associate with Survival in an 85-Year-Old Population-Based Cohort Followed until Death.
Ribbe M; Kern S; Börjesson Hansson A; Östling S; Zetterberg H; Blennow K; Skoog I
Article: PLOS MEDICINE. 2018;15(9):e1002660
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M; NILVAD Study Group
Article: ALZHEIMER'S RESEARCH AND THERAPY. 2018;10(1):85
Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study
Timmers M; Streffer JR; Russu A; Tominaga Y; Shimizu H; Shiraishi A; Tatikola K; Smekens P; Borjesson-Hanson A; Andreasen N; Matias-Guiu J; Baquero M; Boada M; Tesseur I; Tritsmans L; Van Nueten L; Engelborghs S
Article: NEUROLOGY. 2018;90(19):e1682-e1691
Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.
Kern S; Zetterberg H; Kern J; Zettergren A; Waern M; Höglund K; Andreasson U; Wetterberg H; Börjesson-Hanson A; Blennow K; Skoog I
Article: JOURNAL OF ALZHEIMER'S DISEASE. 2018;62(4):1877-1886
Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.
Skoog I; Kern S; Zetterberg H; Östling S; Börjesson-Hanson A; Guo X; Blennow K
Article: ALZHEIMER'S AND DEMENTIA. 2018;14(3):280-292
Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study
Skrobot OA; Black SE; Chen C; DeCarli C; Erkinjuntti T; Ford GA; Kalaria RN; O'Brien J; Pantoni L; Pasquier F; Roman GC; Wallin A; Sachdev P; Skoog I; Ben-Shlomo Y; Passmore AP; Love S; Kehoe PG; Taragano FE; Kril J; Cavalieri M; Jellinger KA; Kovacs GG; Engelborghs S; Lafosse C; Bertolucci PH; Brucki S; Caramelli P; Alves TCDTF; Bocti C; Fulop T; Hogan DB; Hsiung GR; Kirk A; Leach L; Robillard A; Sahlas DJ; Guo Q; Tian J; Hokkanen L; Jokinen H; Benisty S; Deramecourt V; Hauw J; Lenoir H; Tsatali M; Tsolaki M; Sundar U; Coen RF; Korczyn AD; Altieri M; Baldereschi M; Caltagirone C; Caravaglios G; Di Carlo A; Di Piero V; Gainotti G; Galluzzi S; Logroscino G; Mecocci P; Moretti DV; Padovani A; Fukui T; Ihara M; Mizuno T; Kim SY; Akinyemi R; Baiyewu O; Ogunniyi A; Szczudlik A; Bastos-Leite AJ; Firmino H; Massano J; Verdelho A; Kruglov LS; Ikram MK; Kandiah N; Arana E; Barroso-Ribal J; Calatayud T; Cruz-Jentoft AJ; Lopez-Pousa S; Martinez-Lage P; Mataro M; Borjesson-Hanson A; Englund E; Laukka EJ; Qiu C; Viitanen M; Biessels GJ; de Leeuw F-E; den Heijer T; Exalto LG; Kappelle LJ; Prins ND; Richard E; Schmand B; van den Berg E; van der Flier WM; Bilgic B; Allan LM; Archer J; Attems J; Bayer A; Blackburn D; Brayne C; Bullock R; Connelly PJ; Farrant A; Fish M; Harkness K; Ince PG; Langhorne P; Mann J; Matthews FE; Mayer P; Pendlebury ST; Perneczky R; Peters R; Smithard D; Stephan BC; Swartz JE; Todd S; Werring DJ; Wijayasiri SN; Wilcock G; Zamboni G; Au R; Borson S; Bozoki A; Browndyke JN; Corrada MM; Crane PK; Diniz BS; Etcher L; Fillit H; Greenberg SM; Grinberg LT; Hurt SW; Lamar M; Mielke M; Ott BR; Perry G; Powers WJ; Ramos-Estebanez C; Reed B; Roberts RO; Romero JR; Saykin AJ; Seshadri S; Silbert L; Stern Y; Zarow C
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2018;46(1-2):90-99
Midlife Stress in Relation to Late-Life Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: A 25-Year Follow-Up Study.
Johansson L; Kern S; Zetterberg H; Blennow K; Börjesson-Hansson A; Rosengren L; Guo X; Skoog I
Article: ALZHEIMER’S & DEMENTIA: TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2017;3(3):393-401
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study.
Landen JW; Andreasen N; Cronenberger CL; Schwartz PF; Börjesson-Hanson A; Östlund H; Sattler CA; Binneman B; Bednar MM
Article: SCIENTIFIC REPORTS. 2017;7(1):6136
Decreasing prevalence of dementia in 85-year olds examined 22 years apart: the influence of education and stroke.
Skoog I; Börjesson-Hanson A; Kern S; Johansson L; Falk H; Sigström R; Östling S
Article: ALZHEIMER'S AND DEMENTIA. 2017;13(6):624-633
The Vascular Impairment of Cognition Classification Consensus Study
Skrobot OA; O'Brien J; Black S; Chen C; DeCarli C; Erkinjuntti T; Ford GA; Kalaria RN; Pantoni L; Pasquier F; Roman GC; Wallin A; Sachdev P; Skoog I; Ben-Shlomo Y; Passmore AP; Love S; Kehoe PG; Taragano FE; Kril J; Cavalieri M; Jellinger KA; Kovacs GG; Engelborghs S; Lafosse C; Bertolucci PH; Brucki S; Caramelli P; Alves TCDTF; Bocti C; Fulop T; Hogan DB; Hsiung GR; Kirk A; Leach L; Robillard A; Sahlas DJ; Guo Q; Tian J; Hokkanen L; Jokinen H; Benisty S; Deramecourt V; Hauw J; Lenoir H; Tsatali M; Tsolaki M; Sundar U; Coen RF; Korczyn AD; Altieri M; Baldereschi M; Caltagirone C; Caravaglios G; Di Carlo A; Di Piero V; Gainotti G; Galluzzi S; Logroscino G; Mecocci P; Moretti DV; Padovani A; Fukui T; Ihara M; Mizuno T; Kim SY; Akinyemi R; Baiyewu O; Ogunniyi A; Szczudlik A; Bastos-Leite AJ; Firmino H; Massano J; Verdelho A; Kruglov LS; Ikram MK; Kandiah N; Arana E; Barroso-Ribal J; Calatayud T; Cruz-Jentoft AJ; Lopez-Pousa S; Martinez-Lage P; Mataro M; Borjesson-Hanson A; Englund E; Laukka EJ; Qiu C; Viitanen M; Biessels GJ; de Leeuw F-E; den Heijer T; Exalto LG; Kappelle LJ; Prins ND; Richard E; Schmand B; van den Berg E; van der Flier WM; Bilgic B; Allan LM; Archer J; Attems J; Bayer A; Blackburn D; Brayne C; Bullock R; Connelly PJ; Farrant A; Fish M; Harkness K; Ince PG; Langhorne P; Mann J; Matthews FE; Mayer P; Pendlebury ST; Perneczky R; Peters R; Smithard D; Stephan BC; Swartz JE; Todd S; Werring DJ; Wijayasiri SN; Wilcock G; Zamboni G; Au R; Borson S; Bozoki A; Browndyke JN; Corrada MM; Crane PK; Diniz BS; Etcher L; Fillit H; Greenberg SM; Grinberg LT; Hurt SW; Lamar M; Mielke M; Ott BR; Perry G; Powers WJ; Ramos-Estebanez C; Reed B; Roberts RO; Romero JR; Saykin AJ; Seshadri S; Silbert L; Stern Y; Zarow C
Article: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2017;65(6):1296-1300
A Longitudinal Study of the Mini-Mental State Examination in Late Nonagenarians and Its Relationship with Dementia, Mortality, and Education.
Skoog J; Backman K; Ribbe M; Falk H; Gudmundsson P; Thorvaldsson V; Borjesson-Hanson A; Ostling S; Johansson B; Skoog I
Article: TRANSLATIONAL PSYCHIATRY. 2017;7(1):e995
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
Hoglund K; Kern S; Zettergren A; Borjesson-Hansson A; Zetterberg H; Skoog I; Blennow K
Article: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2016;24(12):1237-1245
DSM-IV and DSM-5 Prevalence of Social Anxiety Disorder in a Population Sample of Older People
Karlsson B; Sigstrom R; Ostling S; Waern M; Borjesson-Hanson A; Skoog I
Article: NEUROLOGY. 2016;87(16):1674-1680
Calcium supplementation and risk of dementia in women with cerebrovascular disease.
Kern J; Kern S; Blennow K; Zetterberg H; Waern M; Guo X; Börjesson-Hanson A; Skoog I; Östling S
Article: BMJ OPEN. 2016;6(7):e011584
European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow.
Meulenbroek O; O'Dwyer S; de Jong D; van Spijker G; Kennelly S; Cregg F; Olde Rikkert M; Abdullah L; Wallin A; Walsh C; Coen R; Kenny RA; Daly L; Segurado R; Borjesson-Hanson A; Crawford F; Mullan M; Lucca U; Banzi R; Pasquier F; Breuilh L; Riepe M; Kalman J; Molloy W; Tsolaki M; Howard R; Adams J; Gaynor S; Lawlor B
Article: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2016;42(2):194-209
Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
Craggs LJL; Taylor JL; Slade JY; Chen A; Hagel C; Kuhlenbaeumer G; Borjesson-Hanson A; Viitanen M; Kalimo H; Deramecourt V; Oakley AE; Kalaria RN
Article: JOURNAL OF ALZHEIMER'S DISEASE. 2015;49(3):733-741
Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years.
Bjerke M; Kern S; Blennow K; Zetterberg H; Waern M; Börjesson-Hanson A; Östling S; Kern J; Skoog I
Article: BIOLOGICAL PSYCHIATRY. 2015;78(10):730-736
A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden.
Skoog I; Waern M; Duberstein P; Blennow K; Zetterberg H; Börjesson-Hanson A; Östling S; Guo X; Kern J; Gustafson D; Gudmundsson P; Marlow T; Kern S
Article: ALZHEIMER'S AND DEMENTIA. 2015;11(4):425-433
Effect of diagnostic criteria on prevalence of frontotemporal dementia in the elderly.
Gislason TB; Östling S; Börjesson-Hanson A; Sjögren M; Simoni M; Pantoni L; Skoog I
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2014;41:55-58
Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample.
Kern S; Skoog I; Börjesson-Hanson A; Blennow K; Zetterberg H; Ostling S; Kern J; Gudmundsson P; Marlow T; Rosengren L; Waern M
Article: JOURNAL OF NEUROIMAGING. 2014;24(5):444-452
Different stages of white matter changes in the original HDLS family revealed by advanced MRI techniques.
Sundal C; Jönsson L; Ljungberg M; Zhong J; Tian W; Zhu T; Linden T; Börjesson-Hanson A; Andersen O; Ekholm S
Article: PARKINSONISM AND RELATED DISORDERS. 2013;19(10):869-877
Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.
Sundal C; Fujioka S; Van Gerpen JA; Wider C; Nicholson AM; Baker M; Shuster EA; Aasly J; Spina S; Ghetti B; Roeber S; Garbern J; Tselis A; Swerdlow RH; Miller BB; Borjesson-Hanson A; Uitti RJ; Ross OA; Stoessl AJ; Rademakers R; Josephs KA; Dickson DW; Broderick D; Wszolek ZK
Article: BRAIN PATHOLOGY. 2013;23(5):547-557
Quantitative Vascular Pathology and Phenotyping Familial and Sporadic Cerebral Small Vessel Diseases
Craggs LJL; Hagel C; Kuhlenbaeumer G; Borjesson-Hanson A; Andersen O; Viitanen M; Kalimo H; McLean CA; Slade JY; Hall RA; Oakley AE; Yamamoto Y; Deramecourt V; Kalaria RN
Article: AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2013;25(4):377-383
Prevalence of cardiovascular disorders and risk factors in two 75-year-old birth cohorts examined in 1976-1977 and 2005-2006.
Zhi X; Joas E; Waern M; Östling S; Börjesson-Hanson A; Skoog I
Article: BMJ OPEN. 2013;3(2):e002260
Suicidal feelings in the twilight of life: a cross-sectional population-based study of 97-year-olds.
Fässberg MM; Ostling S; Börjesson-Hanson A; Skoog I; Wærn M
Article: NEUROLOGY. 2012;79(6):566-574
MRI characteristics and scoring in HDLS due to CSF1R gene mutations.
Sundal C; Van Gerpen JA; Nicholson AM; Wider C; Shuster EA; Aasly J; Spina S; Ghetti B; Roeber S; Garbern J; Borjesson-Hanson A; Tselis A; Swerdlow RH; Miller BB; Fujioka S; Heckman MG; Uitti RJ; Josephs KA; Baker M; Andersen O; Rademakers R; Dickson DW; Broderick D; Wszolek ZK
Article: ACTA NEUROLOGICA SCANDINAVICA. 2012;126(1):67-75
Update of the original HDLS kindred: divergent clinical courses
Sundal C; Ekholm S; Nordborg C; Jonsson L; Borjesson-Hanson A; Linden T; Zetterberg H; Viitanen M; Andersen O
Article: AGE AND AGEING. 2012;41(4):529-533
A population-based study on dementia and stroke in 97 year olds.
Andersson M; Guo X; Börjesson-Hanson A; Liebetrau M; Östling S; Skoog I
Article: PSYCHOLOGY AND AGING. 2012;27(2):375-383
Nonlinear blood pressure effects on cognition in old age: separating between-person and within-person associations.
Thorvaldsson V; Skoog I; Hofer SM; Börjesson-Hanson A; Ostling S; Sacuiu S; Johansson B
Article: BMJ OPEN. 2012;2(5):e001288
Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women.
Kern S; Skoog I; Ostling S; Kern J; Börjesson-Hanson A
Article: INTERNATIONAL PSYCHOGERIATRICS. 2011;23(8):1270-1277
Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study.
Lesén E; Carlsten A; Skoog I; Waern M; Petzold M; Börjesson-Hanson A
Article: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2011;19(3):284-291
One-month prevalence of mental disorders in a population sample of 95-year olds.
Börjesson-Hanson A; Waern M; Ostling S; Gustafson D; Skoog I
Article: JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2011;24(1):3-8
Psychotic symptoms in a population-based sample of 85-year-old individuals with dementia.
Ostling S; Gustafson D; Blennow K; Börjesson-Hanson A; Waern M
Article: JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY. 2011;17(1):154-162
Onset and Rate of Cognitive Change Before Dementia Diagnosis: Findings From Two Swedish Population-Based Longitudinal Studies
Thorvaldsson V; MacDonald SWS; Fratiglioni L; Winblad B; Kivipelto M; Laukka EJ; Skoog I; Sacuiu S; Guo X; Ostling S; Borjesson-Hanson A; Gustafson D; Johansson B; Backman L
Article: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2007;15(12):1034-1045
Diagnostic criteria influence dementia prevalence.
Wancata J; Börjesson-Hanson A; Ostling S; Sjögren K; Skoog I
Article: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2007;15(12):999-1004
Psychotic symptoms and paranoid ideation in a population-based sample of 95-year-olds.
Ostling S; Börjesson-Hanson A; Skoog I
Article: NEUROLOGY. 2007;69(22):2069-2075
Five-year mortality in relation to dementia and cognitive function in 95-year-olds.
Börjesson-Hanson A; Gustafson D; Skoog I
Article: BRAIN. 2007;130(Pt 2):357-367
Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL
Low WC; Junna M; Borjesson-Hanson A; Morris CM; Moss TH; Stevens DL; St Clair D; Mizuno T; Zhang WW; Mykkanen K; Wahlstrom J; Andersen O; Kalimo H; Viitanen M; Kalaria RN
Article: NEUROLOGY. 2004;63(12):2436-2438
The prevalence of dementia in 95 year olds.
Börjesson-Hanson A; Edin E; Gislason T; Skoog I
Article: SCANDINAVIAN JOURNAL OF CARING SCIENCES. 2002;16(1):91-102
Colour perception among the very elderly related to visual and cognitive function.
Wijk H; Berg S; Bergman B; Hanson AB; Sivik L; Steen B
Article: AGING. 2001;13(2):68-77
Cognitive function and functional ability. A cross-sectional and longitudinal study at ages 85 and 95 in a non-demented population.
Steen G; Sonn U; Hanson AB; Steen B
Show more

All other publications

Corrigendum: NATURE MEDICINE. 2024;30(1):304
Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Mummery CJ; Börjesson-Hanson A; Blackburn DJ; Vijverberg EGB; De Deyn PP; Ducharme S; Jonsson M; Schneider A; Rinne JO; Ludolph AC; Bodenschatz R; Kordasiewicz H; Swayze EE; Fitzsimmons B; Mignon L; Moore KM; Yun C; Baumann T; Li D; Norris DA; Crean R; Graham DL; Huang E; Ratti E; Bennett CF; Junge C; Lane RM
Letter: TRANSLATIONAL NEURODEGENERATION. 2023;12(1):24
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter
LaBarbera KM; Sheline YI; Izzo NJ; Yuede CM; Waybright L; Yurko R; Edwards HM; Gardiner WD; Blennow K; Zetterberg H; Borjesson-Hanson A; Morgan R; Davis CS; Guttendorf RJ; Schneider LS; DeKosky S; LeVine HIII; Grundman M; Caggiano AO; Cirrito JR; Catalano SM; Hamby ME
Corrigendum: TRANSLATIONAL PSYCHIATRY. 2018;8(1):250
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration (vol 7, e995, 2017)
Hoglund K; Kern S; Zettergren A; Borjesson-Hansson A; Zetterberg H; Skoog I; Blennow K
Letter: BRAIN. 2017;140(5):e29
Multi-infarct dementia of Swedish type is caused by a 3′UTR mutation of COL4A1
Siitonen M; Borjesson-Hanson A; Poyhonen M; Ora A; Pasanen P; Bras J; Kern S; Kern J; Andersen O; Stanescu H; Kleta R; Baumann M; Kalaria R; Kalimo H; Singleton A; Hardy J; Viitanen M; Myllykangas L; Guerreiro R
Review: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36(1):114-131
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.
Wallin A; Nordlund A; Jonsson M; Lind K; Edman Å; Göthlin M; Stålhammar J; Eckerström M; Kern S; Börjesson-Hanson A; Carlsson M; Olsson E; Zetterberg H; Blennow K; Svensson J; Öhrfelt A; Bjerke M; Rolstad S; Eckerström C
Letter: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2015;181(3):214-217
The distribution of apolipoprotein E genotype over the adult lifespan and in relation to country of birth.
Kern S; Mehlig K; Kern J; Zetterberg H; Thelle D; Skoog I; Lissner L; Blennow K; Börjesson-Hanson A
Corrigendum: BRAIN, BEHAVIOR, AND IMMUNITY. 2014;36:216
Retraction notice to "Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years" [Brain Behav. Immun. 32 (2013) 153-158].
Editorial comment: NEUROLOGY. 2011;76(10):879-886
A population-based study on the influence of brain atrophy on 20-year survival after age 85.
Olesen PJ; Guo X; Gustafson D; Börjesson-Hanson A; Sacuíu S; Eckerström C; Bigler ED; Skoog I
Letter: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2006;32(4):455-458
Cerebral arteriolar pathology in a 32-year-old patient with CADASIL
Miao Q; Kalimo H; Bogdanovic N; Kostulas K; Borjesson-Hanson A; Viitanen M

Articles

All other publications

News from KI

Events from KI